Cost-Effectiveness of Dolutegravir, a New Generation Integrase Inhibitor, in Hiv-1 Treatment Experienced Patients in France

Value Health. 2014 Nov;17(7):A678-9. doi: 10.1016/j.jval.2014.08.2526. Epub 2014 Oct 26.

Authors

N Despiégel¹, A G Marcellin², C Aubin³, C Espinas¹, A Laurisse⁴, G Pialoux⁵

Affiliations

¹ Optum, Nanterre, France.
² AP-HP, Hôpital Pitié-Salpêtrière, Paris, France.
³ Glaxo Smith Kline, Marly-le-Roi, France.
⁴ ViiV Healthcare France, Marly-le-Roi, France.
⁵ APHP, Hôpital Tenon, Paris, France.

PMID: 27202502
DOI: 10.1016/j.jval.2014.08.2526

No abstract available